Understanding the motivations of health-care providers in performing female genital mutilation: an integrative review of the literature by Marie-Hélène Doucet et al.
REVIEW Open Access
Understanding the motivations of health-
care providers in performing female genital
mutilation: an integrative review of the
literature
Marie-Hélène Doucet1* , Christina Pallitto2 and Danielle Groleau1,3
Abstract
Background: Female genital mutilation (FGM) is a traditional harmful practice that can cause severe physical and
psychological damages to girls and women. Increasingly, trained health-care providers carry out the practice at the
request of families. It is important to understand the motivations of providers in order to reduce the medicalization
of FGM. This integrative review identifies, appraises and summarizes qualitative and quantitative literature exploring
the factors that are associated with the medicalization of FGM and/or re-infibulation.
Methods: Literature searches were conducted in PubMed, CINAHL and grey literature databases. Hand searches of
identified studies were also examined. The “CASP Qualitative Research Checklist” and the “STROBE Statement” were
used to assess the methodological quality of the qualitative and quantitative studies respectively. A total of 354
articles were reviewed for inclusion.
Results: Fourteen (14) studies, conducted in countries where FGM is largely practiced as well as in countries
hosting migrants from these regions, were included. The main findings about the motivations of health-care
providers to practice FGM were: (1) the belief that performing FGM would be less harmful for girls or women
than the procedure being performed by a traditional practitioner (the so-called “harm reduction” perspective);
(2) the belief that the practice was justified for cultural reasons; (3) the financial gains of performing the procedure; (4)
responding to requests of the community or feeling pressured by the community to perform FGM. The main reasons
given by health-care providers for not performing FGM were that they (1) are concerned about the risks that FGM can
cause for girls’ and women’s health; (2) are preoccupied by the legal sanctions that might result from performing FGM;
and (3) consider FGM to be a “bad practice”.
Conclusion: The findings of this review can inform public health program planners, policy makers and researchers to
adapt or create strategies to end medicalization of FGM in countries with high prevalence of this practice, as well as in
countries hosting immigrants from these regions. Given the methodological limitations in the included studies, it is clear
that more robust in-depth qualitative studies are needed, in order to better tackle the complexity of this phenomenon
and contribute to eradicating FGM throughout the world.
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Résumé
Contexte: Les mutilations génitales féminines (MGF) peuvent gravement affecter la santé physique et psychologique
des filles et des femmes. De plus en plus de professionnels formés pour donner des soins de santé pratiquent les MGF
à la demande des familles. Il importe de connaître les motivations de ceux-ci afin de réduire la médicalisation des MGF.
Cette revue intégrative identifie, évalue et résume la littérature scientifique qualitative et quantitative explorant
les facteurs associés à la médicalisation des MGF ou de la ré-infibulation.
Méthodes: Les recherches ont été menées dans PubMed, CINAHL et des bases de données de la littérature grises. Les
références des études identifiées ont aussi été examinées. Les listes de vérification du CASP et de l’énoncé STROBE ont
été utilisées pour évaluer la qualité méthodologique des études qualitatives et quantitatives. Au total, 354 articles ont
été révisés pour inclusion.
Résultats: Quatorze études, menées dans des pays où les MGF sont pratiquées et dans des pays accueillant des
migrants, ont été incluses. Les principales motivations nommées par le personnel de santé pour pratiquer les
MGF étaient: (1) croire que cela réduira les risques pour la santé des filles, par opposition à l’exécution par une
exciseuse traditionnelle (“réduction des méfaits”); (2) pratiquer pour des raisons culturelles; (3) bénéficier de
gains financiers; (4) répondre aux demandes ou ressentir une pression provenant de la communauté pour effectuer les
MGF. Les principales raisons pour lesquelles certains professionnels de la santé ne pratiquent pas les MGF étaient qu’ils
(1) sont préoccupés par les risques encourus pour la santé des filles et des femmes; (2) craignent des sanctions légales;
et (3) considèrent les MGF comme étant une “mauvaise pratique”.
Conclusion: Les résultats de cette recension permettent d’informer les planificateurs de santé publique, les décideurs
et les chercheurs, afin d’adapter ou de créer des stratégies permettant de mettre fin à la médicalisation des MGF dans
les pays à forte prévalence, ainsi que dans les pays qui accueillent les immigrants de ces régions. Cependant, étant
donné les limites méthodologiques importantes des études incluses, des études qualitatives plus robustes sont requises,
afin de mieux lutter contre ce phénomène complexe et contribuer à éradiquer les MGF dans le monde.
Mots-clés: Mutilations génitales féminines (MGF), Réinfibulation, Personnel de santé, Médicalisation, Motivations
Plain English summary
Female genital mutilation (FGM) is a traditional harmful
practice involving the cutting or removal of flesh from
girls’ genitals, and sometimes stitching the vagina closed.
In addition to being a violation of human rights, the
practice increases risk of severe harm to girls and women,
such as sexual problems, complications during childbirth,
psychological problems and even death. While mainly
performed by traditional practitioners, there is an in-
creasing trend of trained health-care providers per-
forming FGM. This review seeks to identify the reasons
why health-care providers perform FGM, or not. The
main reasons identified are (1) the belief that it will
reduce risks for girls or women, as compared to when
it is done by a traditional practitioner; (2) for cultural
reasons; (3) for financial gain; (4) to respond to the
requests of families and community members. The
main reasons why health-care providers do not perform
FGM are that (1) they consider FGM as being a bad
practice; (2) they are concerned about the risks that
FGM can cause for girls’ and women’s health; and (3)
they are preoccupied by the legal sanctions that might
result from performing FGM. These findings can con-
tribute to the development of strategies to end the
practice of FGM by health-care providers. In addition,
there is a need for more research on best approaches to
reduce the medicalization of FGM.
Background
Female genital mutilation
Female genital mutilation (FGM) is an ancient tradition,
practiced in at least 30 countries of Africa, the Middle-
East and Asia [1]. It is estimated that there are currently
200 million women and girls living with FGM [1], and
that more than 3 million girls are at risk of being cut
every year [2]. FGM involves the partial or total removal
of the external female genitalia, or other injury to the
female genital organs for non-medical reasons [3]. Dif-
ferent forms of FGM include clitoridectomy (partial or
total removal of the clitoris, referred to as Type 1), exci-
sion (partial or total removal of the clitoris and the labia
minora, with or without excision of the labia majora,
Type 2), and other forms such as pricking, piercing, in-
cising, scraping and cauterizing the genitals (Type 4).
The most severe form of FGM (Type 3) also known as
infibulation involves the removal of the clitoris and labia
minora, and stitching closed of the labia majora [4].
Women who have undergone Type 3 may have a pro-
cedure called de-infibulation, which involves opening
the infibulation scar in order to facilitate childbirth or to
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prevent complications from the infibulation. Some women
or their families request re-infibulation after childbirth to
restore the genitalia to the state that they were in as a
result of infibulation [3]. Immediate risks of FGM include
intense pain, haemorrhage (excessive bleeding), shock, dif-
ficult urination and infection [5]. In the long term, FGM
can also give rise to reproductive health problems, such as
dyspareunia (difficulty having sexual intercourse), compli-
cations during childbirth and even neonatal death, par-
ticularly among women who have been infibulated [6, 7].
Moreover, psychological health problems such as anxiety,
depression and post-traumatic stress disorder are associ-
ated with this practice [8, 9]. Furthermore, some girls and
women do not survive the complications of FGM such
as haemorrhage, infections (e.g., tetanus) and obstructed
labour [2, 10, 11]. Lastly, FGM yields no health benefit [4].
Hence, these practices represent an important public
health problem, and a violation of the fundamental rights
to security, health and life [4, 12, 13].
The prevalence of FGM varies from one region to an-
other, and is for example almost universal in Somalia (98%)
and Guinea (97%), very high in Mali (89%), Egypt and
Sudan (87%), relatively low in Senegal (25%) and almost
non-existent in Cameroon (1%) [1]. FGM is usually
practiced on girls younger than 15 years old [2]. The
reasons given to justify this custom are diverse, and
mainly reflect cultural and social dimensions [4, 14], in-
cluding cultural ideals of beauty and “cleanliness”, and
are a pivotal part of the rite of passage to adulthood [2,
14, 15]. As it is rooted in gender inequality, FGM is
intended to control women’s sexuality and safeguard
the honour of the family [2, 5] by ensuring virginity
among young girls and marital fidelity among married
women [2, 16]. In addition, FGM would confer girls the
status of eligibility for marriage [2]. In communities
where FGM is nearly universal, mothers may not ques-
tion the practice for their daughters [2, 15]. FGM tends
to be practiced more in rural areas compared to urban
areas [2], with the ethnicity being the most important
factor predicting the prevalence and type of FGM per-
formed [2]. Despite multiple international resolutions
and declarations on ending FGM [17, 18], and diverse
strategies throughout the world to eradicate it, the
practice of FGM persists [1]. This stems from the fact
that the cultural beliefs associated with FGM are central
for practicing communities, which do not consider FGM
as being a form of violence or a “mutilation” [19, 20], and
consequently not as a violation of human rights. On the
contrary, they believe FGM is necessary: indeed, families
have their daughters cut with the intention of providing
them with a viable future [19]. Moreover, FGM is a com-
plex sociocultural phenomenon, and families are generally
under great pressure to have their daughters conform to
the social norm [2, 21]. Therefore, any strategy addressing
FGM should protect human rights in a culturally appro-
priate manner, in order to be respectful to human beings
as well as to prevent policies, programmes or procedures
that could inadvertently cause harm.
The medicalization of female genital mutilation: a “new”
phenomenon
According to the WHO definition, when FGM is per-
formed by any category of health-care provider, it is
referred to as “medicalization of FGM”, which includes
the practice of any type of FGM, as well as re-infibulation,
performed regardless of the setting (i.e., either public or
private, in clinic, at home or elsewhere) [3].
Who performs FGM? FGM is mainly performed by
traditional practitioners (traditional circumcisers or trad-
itional birth attendants). However, in recent years, there has
been a dramatic increase in the proportion of FGM carried
out by health-care providers (defined in the present review
as trained medical doctors, nurses and midwives) in many
settings [2]. Indeed, families are increasingly requesting that
health-care providers perform FGM, based on the belief
that it would prevent health consequences for girls [2, 22].
This phenomenon is thought to be at least partially a result
of the awareness campaigns about the risks of FGM for the
health of girls [3, 23]. In fact, most traditional practitioners
use an unsterilized blade or a razor to perform the cut [2].
Moreover, they generally do not have adequate knowledge
about the anatomy and physiology of the human body and
the principles of infection prevention, nor the training to
treat the consequences of FGM [24]. However, even when
performed with sterile instruments by trained providers,
FGM is not without risk, and the removal of healthy body
parts can result in adverse consequences in the short- and
long-term [3, 25]. Moreover, health-care providers are
generally respected members of the community, and
when they practice FGM, this can give the impression
that the procedure is acceptable and safe, which can
further promote the practice. Since FGM is performed
for sociocultural reasons rather than for medical reasons,
the practice goes against the Hippocratic Oath of “Do no
harm”, and it violates girls’ and women’s right to physical
integrity, health and life. Therefore, the World Health
Organization (WHO), in its Global strategy to stop
health-care providers from performing female genital
mutilation [3], condemns the practice of FGM by
health-care providers, or by anyone else.
Why do health-care providers perform FGM? In order
to be able to address the issue of medicalization, it is
essential to understand the perspective of health-care
providers. Some studies have asked providers whether
they were requested to perform FGM or re-infibulation
[26, 27], but few studies explored the reasons why or
why not they agreed to do so. To our knowledge, only
one review [28] has attempted to assess the reasons for
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which health-care providers practice FGM. However,
this review only focused on medical doctors. In addition,
it found only one study that addressed this objective. No
review was found on the reasons why or why not nurses
and midwives perform FGM, including re-infibulation.
Therefore, this review fills a gap by identifying, appraising
and summarizing qualitative and quantitative evidence on
the motivations of different types of health-care providers
(nurses, midwives and medical doctors) and of future
health-care providers (students of these disciplines) to
perform FGM and/or re-infibulation. This knowledge
will mainly inform public health program planners, policy
makers and researchers for adapting or creating strategies
to end medicalization of FGM in high prevalence countries,




To identify any qualitative or quantitative research on
the medicalization of FGM, an integrative review method
was used. Indeed, the “integrative review method is an ap-
proach that allows for the inclusion of diverse methodolo-
gies (i.e. experimental and non-experimental research)” [29].
A systematic search strategy was developed for PubMed and
CINAHL databases for peer-reviewed articles, using
controlled vocabulary and free keywords, combining 2
concepts: (a) female genital mutilation; and (b) health-care
providers, including medicalization (Additional file 1).
Searches were conducted during March and April 2016
and updated in August 2016. No language restrictions
were imposed, but dates were limited to 2001-2016.
Additional searches were also performed in Google
Scholar, WHO Library & Information Networks for
Knowledge Database (WHOLIS), WHO Global Health
Library and Open Grey to search for remaining peer-
reviewed studies as well as for grey literature, such as
research reports produced by non-governmental orga-
nizations. EThOS was used to search for PhD theses.
Finally, a manual search of the reference list of all in-
cluded studies, as well as reports [2, 3] and reviews on
knowledge, experiences and attitudes of health-care
providers about FGM [28, 30] was also conducted.
Selection of studies
The inclusion criteria used were the following: (1) the
study described was a primary study; (2) only recent
years (2001–2016) were included, since practices around
medicalization have changed in the past 10–15 years; (3)
the study appeared in a peer-reviewed journal, in the
grey literature from recognized institutions and/or
governments, or was a PhD thesis; (4) the population
researched included health-care providers of any type
(physicians, nurses, or midwives), or students of these
professions; (5) the study related to the topic of
medicalization, including on the motivations of prac-
ticing FGM. There were no restrictions on (a) the
methodology: both quantitative or qualitative studies
were included; (b) the setting: all were considered (i.e.,
public practice, private practice, including at the home
of the girls or the home of the health-care provider);
(c) the countries: studies assessing the practices of
health-care providers practicing in regions with high
prevalence of FGM or in countries hosting immigrants
from high prevalence regions were all examined. Studies
were excluded if health-care providers were not the popula-
tion under study, if there was no mention whether health-
care providers performed FGM and/or re-infibulation, or if
the reasons for which providers perform FGM and/or
re-infibulation (or not) were not reported.
Quality assessment
An assessment of the methodological quality and limita-
tions of the included studies was undertaken. An enriched
version of the “Critical Appraisal Skills Programme (CASP)
Qualitative Research Checklist” [31] was used for the
qualitative studies. The criteria include the following
ten domains, all of which were included in this assess-
ment: the aims of the research, the methodology, the
research design, the recruitment strategy, the data
collection, the reflexivity of researchers, the ethical con-
siderations, the rigor of data analysis, the findings, and
the value of the research. One criterion was added to
the list, which pertains to the mention of possible bias
or limits of the study, for a total of 34 items (Additional
file 2). The checklist of essential items of the “STROBE
(Strengthening the Reporting of Observational studies
in Epidemiology) Statement” [32] was used to assess
the quality of the quantitative studies. This checklist
was in fact not designed to appraise quality, but rather
to guide researchers for the reporting of observational
studies [33]. However, in the absence of a tool designed
to judge the methodological quality of surveys, the
STROBE Statement was used as a proxy. Moreover, this
checklist was modified, since some criteria do not
pertain to survey study designs. The 26 included items
related to the title, the abstract, the introduction, the
methods, the results and the discussion sections of arti-
cles. Likewise, a criterion was added to the list pertaining
to ethical considerations and more precisely for appraising
whether the study was examined and approved by a re-
search ethics committee. The modified version of the check-
list comprised a total of 26 sub-items (Additional file 3).
Thereby, each study was given a score, which was the
number of criteria addressed as a percentage of the
total number of applicable items. Any criterion that
was met has received a score of 1, an item partially met
was marked as 0.5, and a completely absent criterion
Doucet et al. Reproductive Health  (2017) 14:46 Page 4 of 15
received the grade of 0. A score of 75% or above was con-
sidered as “high” quality, a score of 50–74% reflected
“moderate” quality, a score of 25–49% was judged as “low”
quality, and a score below 25% was counted as “very low”
quality. Because of the paucity of studies found, no study
was excluded because of the score; however, the quality
scores indicate the level of confidence we can attribute to
the findings of this review.
Data extraction & synthesis
Each study was systematically examined for all relevant
information, which was compiled in a matrix. The
extracted data included the following domains: year of
the publication; country where the study took place;
aim of the study; type of study/design; methods used
for data collection; type of health-care providers under
study; sample size; form of FGM (i.e., Type 1, 2, 3 and/or
4 FGM, and/or re-infibulation) (Table 1). Furthermore, for
the qualitative studies, a thematic analysis was conducted,
based on the verbatim, results and interpretations re-
ported in the articles. All relevant text units were
coded, extracted, and classified in a matrix into two
broad categories: “reasons to perform FGM” and “rea-
sons not to perform FGM”. The extracted text units
were further categorized in an inductive and iterative
manner into the themes that emerged from the data.
For the quantitative studies, the motivating factors
were directly exported into the matrix. At the end of this
process, a verification of the extracted themes was under-
taken with the primary data, in order to ensure accuracy
of the review findings.
Report
This integrative review is reported following the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [34].
Results
Three hundred ninety-seven (397) articles were identified
through database searches, from which 59 duplicates were
excluded, and 16 articles were identified through manual
search of reference lists, for a total of 354 articles. Titles
and abstracts were then screened to determine whether
they were eligible for inclusion, and 40 full texts were
examined. A total of 14 studies were included in this
review. The search strategy flow diagram is presented
in Fig. 1.
Description of studies
Three (3) studies used qualitative data, nine were quanti-
tative studies (descriptive), and two used mix-methods,
using both qualitative and quantitative designs. Nine (9)
studies related to the practice of FGM, two studies spe-
cifically focussed on re-infibulation, and three studies
addressed both explicitly. Several studies included more
than one type of health-care providers: seven studies
examined the practice of nurses, seven of midwives and
seven of medical doctors. Finally, a total of 10 studies
were carried out in five countries where FGM is prevalent
(i.e., Egypt, Sudan, Kenya, Nigeria and The Gambia), and
four were undertaken in countries where FGM is not the
social norm, but where women and girls from “FGM
countries” immigrate (i.e., United Kingdom, Belgium,
Australia and United-States of America). The summary
of the articles reviewed as well as the summary of their
characteristics are presented in Tables 1 and 2 respectively.
Quality assessment of studies
The quality was disparate across studies, with scores
varying between 24 and 76%. In fact, the quality assess-
ment of included studies revealed that only one study
had a high methodological quality [35]. Ten (10) studies
had moderate methodological limitations [36–45], two
were rated as being of low quality [46, 47], and the sci-
entific report of one study provided very limited infor-
mation for the reader to assess the rigor and quality of
the research and was therefore judged as being of very
low quality [48].
Among the shortcomings identified in the included
studies, an inconsistency was revealed about the defin-
ition used of what constitutes a health-care provider. In-
deed, an author first presented the providers as being
“midwives”, whereas in his methods section, he clarified
that they were in reality traditional birth attendants [46],
and that most of them were illiterate (63.1%). Another
researcher stratified his sample according to 3 regions of
the country, and equated geographical variables with
cultural characteristics [37]. However, this seemingly ar-
bitrary characterization cannot adequately represent a
proxy for the culture.
Review of evidence
The themes and sub-themes extracted from the studies
about the reasons why health-care providers perform
FGM or re-infibulation and the reasons why they do not
perform FGM are presented in Table 3. These are also
described in the sections below.
Reasons health-care providers perform FGM, including re-
infibulation
The key findings about the motivating factors for health-
care providers to practice FGM and/or re-infibulation
can be grouped under the following themes: for harm
reduction (as compared to the procedure being carried
out by a traditional practitioner), for cultural reasons,
for financial reasons, and to respond to community’s re-
quest or pressure.
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Harm reduction A proportion of health-care providers
practice FGM or re-infibulation to prevent or reduce the
risks for girls and women of undergoing the procedure
with a traditional practitioner [35, 37, 38, 40, 41, 44, 47, 48].
According to them, carrying out the procedure under
hygienic conditions would reduce the harm for girls
[38, 47]. Future health-care providers also mentioned
that the medicalized procedure would reduce pain for
girls, with the administration of anaesthetic medication
[38]. In an exploratory study, it was even found that
some midwives with a negative attitude towards FGM
choose to practice re-infibulation “because someone
else would do it worse” [35]. Finally, in a country like
Belgium where FGM is not the social norm, 21.2% of
the 333 gynaecologists surveyed agreed that FGM
should be performed by a medical doctor as a harm re-
duction strategy [44].
Cultural reasons Many health-care providers used
cultural reasons to justify their practice of FGM
[35, 37, 39, 40, 46, 48], such as a study in which
half (52.4%) of the Egyptian physicians practicing
FGM were convinced of the benefits of the tradition
[37]. In a study among nurses in Nigeria, researchers
found that the main predictor for practicing FGM was the
ethnic group, interpreting that their practice is influenced
by their cultural beliefs [39]. However, no more detail
about what was considered a “cultural reason” was given
Fig. 1 Flow diagram of search strategy
Table 2 Summary of the characteristics of included studies
Characteristics of included studies Description n References
Type of studies Qualitative 3 [35, 36, 48]
Quantitative - descriptive 9 [37–44, 46]
Mixed (qualitative and quantitative) 2 [45, 47]
Form of FGM FGM (Types 1, 2, 3 and/or 4) 9 [37–42, 46–48]
Re-infibulation 2 [35, 45]
FGM & re-infibulation 3 [36, 43, 44]
Type of health-care provider Nurses 7 [39–43, 47, 48]
Midwives 7 [35, 36, 41, 43, 45–47]
Physicians 7 [37, 42, 43, 47, 48]
Gynaecologists: [44]
Medical students: [38]
Country where the research took place Country where FGM is prevalent 10 [35, 37–42, 46–48]
Country of immigration (where FGM
is not prevalent)
4 [36, 43–45]
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by the researchers in the studies using survey instru-
ments. In a qualitative study there was a trend among
midwives to encourage women to undergo re-infibulation
after childbirth, because the providers believed that it would
enhance women’s value and protect their marriage, as their
husband would want to divorce them if they remained
de-infibulated [35]. These midwives also mentioned that
re-infibulation was important for beautification and whole-
ness of the woman. And finally, in another study, some
nurses and medical doctors explained that they saw them-
selves as safeguards of the FGM tradition in Kenya [48].
Financial reasons Material gains have been found to be
an important incentive for a proportion of health-care
providers performing FGM, either midwives, nurses and
physicians, mostly in the form of money [35, 37, 40, 46, 47]
but also in the form of gifts [47]. Indeed, in the surveys, the
financial gain was often the preferred choice selected as the
reason for practicing FGM [37, 40] or was mentioned by
the health-care providers [46, 47]. In one of the qualitative
studies, the economic benefit of practicing re-infibulation
was also a motivation given by the Sudanese midwives, but
it was not mentioned spontaneously [35].
Responding to community’s request or pressure A
few studies identified the desire of health-care providers
to satisfy the requests of the community in regards to
FGM as a reason for its medicalization. In fact, answering
the sociocultural requests of the Sudanese community
members has been found to be pivotal for midwives to
practice re-infibulation [35]. In another study, 9% of
the Kenyan health-care providers interviewed mentioned
responding to the “traditional/cultural demands” as a rea-
son to perform FGM [47]. Furthermore, a proportion of
health-care providers stated being under the pressure of
the community to perform FGM and/or re-infibulation
[35, 40, 47], for instance to demonstrate their respect for
the community’s cultural values and traditions [47]. Some
consider practicing FGM again in the future if they were
pressured by the family to do so [40].
Other reasons Only one study, in which medical students
were surveyed, found that the medicalization of FGM
would be a “first step towards the prevention” of the FGM
practice [38]. This reason was not suggested in any other
studies using close-ended questionnaires, nor did it emerge
in the narratives of health-care providers in the qualitative
studies. Likewise, only one study, among Sudanese mid-
wives, reported that a religious imperative was motivating
them to perform FGM [46]. Finally, one study, involving
British health-care providers, found that requests for
re-infibulation after childbirth would be granted if it
was legal [43].
Reasons health-care providers do not perform FGM, including
re-infibulation
Fewer studies examined the reasons why providers do
not practice FGM and/or re-infibulation. The main rea-
sons identified pertain to the risks of FGM to girls’ and
women’s health, the concern about legal sanctions that
might arise from performing FGM, and the conviction
that FGM is a “bad practice”.
Health complications of FGM Some health-care pro-
viders refuse to be involved in cutting girls because of the
risks it can involve for girls and women. This was found
in Sudan, where, despite the fact that the vast majority
(80.9%) of the midwives “experienced FGM sometime in
their life”, one-third (33.8%) of them stated they do not
have the intention to practice it in the future because of
possible complications [46]. In the same country, it was
found that some midwives were also reluctant to perform
re-infibulation, questioning the practice for the same
reason [35].
Illegal practice Some studies mentioned the legal liability
of health-care providers as a reason for not performing
FGM [36, 44–46]. This was mainly found in countries
where FGM is not the norm (Belgium, Australia and
United-States of America).
FGM as a “bad practice” In one study, 93.2% of the
Nigerian medical doctors and nurses responded that
FGM was “not a good practice” [42]. However, this survey
did not explore the reasons further. In another study,
Australian midwives were found to have a highly nega-
tive attitude towards FGM by expressing anger towards
this tradition, which could indicate that they consider
FGM to be a bad practice [36].
Other reasons Some providers do not perform the pro-
cedure because they do not believe that FGM is beneficial
for girls. Indeed, 156 of the 193 Egyptian medical doctors
that were surveyed do not practice FGM, and the reason
stated by the majority of them (81.4%) is that they are “un-
convinced about the benefits” of FGM [37]. The same
study was also the only one that mentioned that a propor-
tion of physicians refuse to practice FGM because they
consider themselves to not have the competencies and
specialization to perform this “operation” [37]. The author
did not provide any more detail about this reason.
Discussion
Despite the international human rights principles stating
that every girl’s security, health and life should be pro-
tected [4, 12, 13] and the WHO statement against the
medicalization of FGM [3], an increasingly alarming pro-
portion of health-care providers continue to maintain
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the FGM tradition [2]. For example, in Egypt, the per-
centage of girls that had FGM performed by a health-
care provider was 55% in 1995, and increased to 77% in
2008. An increase in the medicalization of FGM was also
found in Kenya where it increased from 34–41% in one
decade, i.e., between 1998 and 2008–2009. This integra-
tive review illustrates that health-care providers have
several motivations to perform FGM and re-infibulation.
The “harm reduction” rationale seems to be the main
reason why some health-care providers are in favour of
being involved in the medicalization of FGM. Indeed,
those that subscribe to that belief feel the girls would
benefit from undergoing FGM with a health-care pro-
vider, who would use aseptic techniques for the oper-
ation, as opposed to a traditional practitioner. Moreover,
some argue that girls could be spared from the pain of
the procedure by having access to anaesthetic and analgesic
medication (where it is available), and also that health-care
providers are trained to intervene in case of severe bleeding
or infection. However, every provider should know that cut-
ting and/or removing healthy body parts without medical
indication is not without risks and violates medical ethics,
even if done under optimal sanitary conditions. Unfortu-
nately, it was shown that many health-care providers have
poor knowledge about the health risks associated with
FGM, either in countries where FGM is more frequent
[37–42, 46] as well as in countries hosting immigrants
[43, 45]. Therefore, this finding suggests that information
and training about the risks of FGM should be given to all
health-care providers caring for girls and women, includ-
ing in western countries receiving immigrants.
Furthermore, the strategies aimed at eliminating the
practice of FGM have largely focussed on warning about
its risks for girls’ and women’s health [23]. This approach
seems to have failed to reduce the prevalence of FGM,
and to rather lead to an increase of its medicalization to
reduce harm for girls [2, 3, 23]: more families and com-
munities request medicalized FGM, and more health-care
providers offer the service [2]. Although the population
needs to be aware of the immediate and long term risks
associated with FGM, this angle alone “is not sufficient to
undermine a practice based on cultural beliefs and a per-
ceived need to control women’s sexuality and fertility”
[23]. Consequently, public health approaches and policies
targeting FGM should be redesigned to be more compre-
hensive, taking into consideration the sociocultural factors
related to this practice as well as the human rights princi-
ples, in addition to the health issues.
Cultural reasons were also often reported in studies,
showing that many health-care providers do perform
FGM for non-scientific and non-health-related reasons,
such as beliefs about the preference of husbands, cul-
tural identity and beauty criteria. Most of the studies
constituting this review were assessing the motivation of
providers from countries where FGM is prevalent. It is
therefore not surprising that despite their professional
training, they would be influenced by their own cultural
group’s convictions. The fact that some of the providers
either have a positive attitude towards FGM, have under-
gone FGM themselves or have maintained the tradition
for their daughters [35, 38–41, 46, 48] indicates that it is
not always obvious for them to make a distinction
between their personal beliefs and their professional
obligations. On the other hand, health-care providers
working in countries in which FGM is not part of the
culture generally seemed to have negative attitudes
towards this tradition [36]. However, several researchers
assumed that providers working in countries where FGM
is not the norm would be against the practice. This is an
important shortcoming, since some seem to show cultural
relativism and therefore tolerance for practices such as
FGM [43]. Future studies should then take into account
the cultural beliefs of health-care providers about FGM,
no matter the country where they work or come from.
Health-care providers should receive appropriate training
based on the content and guiding principles of the United
Nations interagency statement on ending medicalization
of FGM [3], in order to understand the implications of
FGM for girls and women’s health and sexuality. This
would ensure their professional practice adheres to the
Hippocratic oath of not doing harm, which is an ethical
imperative that every health-care provider should uphold.
The consideration of the financial incentive for health-
care providers to perform FGM and/or re-infibulation also
emerged in this review. As Toubia & Sharief reported in
their review, one Egyptian doctor stated: “It [FGM] is one
of those high gain low risk operations that are too lucra-
tive to forgo unless your license is at stake” [23]. More-
over, bearing in mind that most of the FGM procedures
are undertaken in low income countries, this is an import-
ant motivating factor for providers, and in particular for
nurses and nurse-midwifes known to have lower salaries
than medical doctors. The financial motivation should not
be overlooked in high-income countries as well, and this
should be explored more in-depth in future researches,
particularly as it relates to cosmetic surgeries. Also, any
strategy aimed at ending medicalization of FGM should
take the financial aspect into consideration.
Trying to meet with the community’s expectations, and
even dealing with the social pressure put upon them, are
other key issues in understanding the reasons for which
health-care providers perform FGM and re-infibulation.
Providers need to be taught skills and given support for
dealing with such requests, in order to refuse to contribute
to this tradition. Likewise, professional associations should
take a public stand against the practice of FGM and
re-infibulation, and should disseminate their consensus
statement to their members and to society at large to help
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reduce the community pressure on providers. For ex-
ample, such statements were issued by the International
Federation of Gynecology and Obstetrics [49], the Society
of Obstetricians and Gynaecologists of Canada [10] and
the Royal College of Obstetricians & Gynaecologists of
United Kingdom [50].
Additionally, the fact that FGM is being legally banned
in many countries seems to influence some health-care
providers’ decisions about not to perform the interven-
tion, whereas some others seem to allow themselves to
practice FGM because no law forbids them to do so, or
because the law is not enforced. It is noteworthy that the
majority of governments of high prevalence countries rec-
ognise that FGM is a violation of human rights [23]. Nearly
all countries where the studies included in this review took
place, had legislation to prohibit the practice of FGM before
the studies were undertaken: this is the case for all the
Western countries, as well as most countries where FGM is
commonly practiced (Egypt (2008); Sudan (2008–2009);
Kenya (2001, 2011) and Nigeria (1999–2006) [2, 51]). The
only exception is The Gambia, where FGM was recently
outlawed (2015) [52]. Interestingly, in the other study
undertaken in Sudan, as well as the studies done in Egypt,
Kenya and Nigeria, the legal issue did not come up in the
findings, which is another demonstration that banning the
practice is insufficient in itself to end the medicalization of
FGM [23]. Indeed, some health-care providers are involved
in the practice despite existing laws [35, 40] and choose to
take the risk of being caught, since other motivations are
important for them. For example, some providers admitted
to discretely performing the act within the walls of the
public health-care centre where they work. And “as most of
the midwives and some of the physicians seemed to be
involved in and aware of the procedures taking place”,
this practice seems to be hidden or even tolerated [35].
Likewise, some providers prefer to practice FGM under-
ground, for example in their own home. Health-care pro-
viders should receive the proper information to better
appropriate the law. Moreover, laws banning the practice of
FGM should be reinforced by sanctioning health-care
providers, either by the suspension or withdrawal of
their professional licence, or by civil punitive measures
(i.e., fine or imprisonment). Health institutions (hospitals
and clinics) allowing or condoning the practice of FGM or
re-infibulation inside their walls should also be held
accountable.
Since some inconsistencies were found in categorizing
some types of health-care professionals, defining what
type of providers to include should be considered when
studying the phenomenon of medicalization of FGM.
Indeed, in some contexts such as low income countries
where a shortage of adequately skilled health professionals
is common [24], the distinction between a professional
trained in a university and an apprentice or self-educated
provider might not always be clear. Recognizing that there
are different cadres of health care providers, some of whom
may lack professional training or competencies, a standard
definition of “medicalization” is proposed. Medicalization of
FGM should refer to “health-care providers” who are pro-
fessionals who have received formal training allowing them
to develop adequate skills and competencies, and who are
recognized by the local ministry of health as having the
right to provide health care.
The studies included in this review help elucidate the
medicalization phenomenon – 9 of them were undertaken
in countries with not only a high proportion of girls and
women having undergone FGM, but also with a high
prevalence of medicalization of FGM, including Egypt
(77%), Sudan (55%), Kenya (42%), and Nigeria (28%) [2].
The Gambia is an exception since despite the high preva-
lence of FGM [1], medicalization is not widely practiced
in this country [2]. However, the study done there showed
that 42.5% of the 468 nurses surveyed embraced the
continuation of FGM, and 42.9% of them think that
medicalization of FGM is safer than when it is per-
formed by a traditional practitioner [41]. These findings
are of great concern and show that an increasing num-
ber of health-care providers could eventually perform
FGM in this context. Moreover, no studies were found
from countries where the medicalization phenomenon
is present, such as in Guinea, where the prevalence of
FGM is as high as 97% [1], and where 27% of FGM is
reported to be done by health-care providers [2]. Since
communities maintain or adopt the practice of FGM
mainly for sociocultural reasons [2], more research is
needed in different regions where health-care providers
perform FGM, in order to tailor strategies to end
medicalization of FGM to each context. As 4 studies were
undertaken in countries hosting immigrants from prac-
ticing nations (United Kingdom, Belgium, Australia,
United-States of America) and revealed that a number
of health-care providers do perform some form of FGM
in these parts of the world also, it is clear that the
phenomenon of medicalization of FGM is a global problem.
Therefore, it should be recognized that medicalization can
be practiced by health-care providers throughout the world.
Limitations of the review
Our findings have several limitations. First, the results of
this review were limited by the fact that most of the
available studies were descriptive, in the form of quantita-
tive surveys with pre-determined answer choices. There-
fore, this suggests the pressing need to develop robust,
in-depth qualitative studies, as well as quantitative
studies that specifically focus on this topic rather than
embedding questions on medicalization in surveys re-
lated to other topics.
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Also, this review identified a relatively small number of
studies (n = 14), with methodological limitations in nearly
all the studies. Furthermore, although the “STROBE
Statement” is a useful tool to improve the reporting of
observational studies, it was not designed to assess quality.
Therefore, a checklist for quality assessment of survey
studies is needed.
Because of the paucity of studies that could be in-
cluded in this review, the findings were not analysed
by the type of health-care providers, nor by the sex of
the providers. Additionally, the lack of information in
many studies made it difficult, and even virtually im-
possible, to specifically distinguish the motivations of
the providers according to the different types of FGM
(i.e., types 1–4 and re-infibulation) they perform. This
should be taken into account in future studies, since
this exploration could reveal different viewpoints about
the medicalization of FGM. The rising trend of “symbolic
circumcision” should also be accounted for, since it is in-
creasingly considered as an “alternative to more severe
forms of cutting” [2] (but it is nonetheless a form of muti-
lation as per WHO). The findings of this review were not
distinguished according to the types of settings in which
health-care providers perform FGM or re-infibulation.
Different contexts might show different motivating
factors for the practice. Also, because the tradition of
FGM has different meanings among diverse sociocul-
tural groups, future studies should consider these nu-
ances [4].
Searches for studies were carried out in the main
pertinent databases as well as in the grey literature.
However, unpublished research findings were not looked
for, which would have allowed to complete this systematic
review of the literature. Finally, since the main literature
can be found in English, a keyword search in other lan-
guages was not undertaken. However, a search in languages
such as in Arabic (which is a major language spoken in East
Africa) and French (which is a major language spoken in
West Africa and in some Western countries) would have
potentially generated some additional articles. Nevertheless,
no study was rejected because of the language.
Conclusion
Many international organisations, such as the World
Health Organization (WHO), the United Nations Children’s
Fund (UNICEF), the United Nations Population Fund
(UNFPA) and the United Nations Development Programme
(UNDP), are jointly working for the eradication of the
female genital mutilation tradition [5]. This study is
the first review that explores the reasons related to the
involvement of health-care providers in the medicalization
of female genital mutilation, either in FGM-prevalent
settings and countries hosting immigrants. The avail-
able findings mainly suggest that health-care providers
need more information and training in order to revert
these harmful practices.
Since not many studies have explored the reasons for
which health-care providers practice medicalization of
FGM, and since several studies had methodological limi-
tations, more research is needed to tackle this complex
phenomenon and to guide efforts to eradicate FGM
around the world. This would ensure a deeper under-
standing of the phenomenon and richer information
for different contexts in order to adequately tailor strat-
egies, programmes, guidelines and trainings for health-
care providers to end the medicalization of FGM.
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